Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of HM11260C in adults with Type 2 diabetes mellitus inadequately controlled with metformin and dapag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HM11260C

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Type 2 Diabetes | Phase 3 | Status: NOT_YET_RECRUITING